Indexed In Scopus
  Scopus ID: 21100926589

Utilization of Nanographene Oxide–Folic Acid–Metal Chalcogen in Cancer Theranostics

Souad A. Elfeky, Nayer Qenawi, Walid Tawfik, Samah A. Loutfy and T.D. Subash


Background: In recent years, cancer theranostics (Diagnosis and treatment) has benefited greatly from using nanomedicine. Nanomaterials have unique biological properties that allow them to use in multi-therapeutic agents such as photothermal treatment (PTT) and photo-dynamic therapy (PDT) and diagnosis, so many researchers are trending recently to get a multimodal platform that achieves high efficiency in cancer theranostic.
Aim of review: This work discusses nanographene oxide (NGO) conjugated folic acid (FA), and some examples of NGO conjugated FA-nanohybrid and its applications in cancer theranostics and metal chalcogen and modified transition metal dichalcogenides (TMD) in cancer theranostics.
Key scientific concepts of review: The work underlines the chemistry, properties, and synthesis of NGO and how it can be conjugated with FA, then explains some examples of NGO-FA-nanohybrid and its application in cancer theranostics as NGO-FA-CuS, which represents NGO-FA-metal chalcogen which indicate that NGO-FA-metal chalcogen is a potential multimode theranostics agent for the advancement of cancer theranostics.

Published on: December 21, 2023
doi: 10.17756/nwj.2023-s5-041
Citation: Elfeky SA, Qenawi N, Tawfik W, Loutfy SA, Subash TD. 2023. Utilization of Nanographene Oxide–Folic Acid–Metal Chalcogen in Cancer Theranostics. NanoWorld J 9(S5): S206-S214.

Download Citation (XML)